MARAGANORE JOHN 4
4 · Kymera Therapeutics, Inc. · Filed Jan 19, 2022
Insider Transaction Report
Form 4
MARAGANORE JOHN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+24,000→ 24,000 totalExercise: $39.61Exp: 2032-01-17→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on January 18, 2022.